A cardiac cath revealed multi-vessel CAD, a decreased ejection fraction, and mitral valve disease.
Followup CT is recommended in [**3-14**] months to reevaluate this area.
[**2106-1-7**] 08:21PM BLOOD WBC-13.5* RBC-3.79* Hgb-11.6* Hct-33.6* MCV-89 MCH-30.5 MCHC-34.4 RDW-14.7 Plt Ct-218 [**2106-1-22**] 02:20AM BLOOD WBC-14.8* RBC-3.92* Hgb-11.5* Hct-34.2* MCV-87 MCH-29.3 MCHC-33.6 RDW-15.4 Plt Ct-144* [**2106-2-2**] 01:07AM BLOOD WBC-14.7*# RBC-3.95* Hgb-11.5* Hct-35.7* MCV-91 MCH-29.2 MCHC-32.3 RDW-15.0 Plt Ct-274 [**2106-2-18**] 04:25AM BLOOD WBC-6.7 RBC-3.52* Hgb-10.2* Hct-31.2* MCV-89 MCH-29.1 MCHC-32.8 RDW-16.0* Plt Ct-198 [**2106-2-5**] 06:10AM BLOOD PT-19.7* PTT-27.2 INR(PT)-1.8* [**2106-2-10**] 05:30PM BLOOD PT-19.0* INR(PT)-1.7* [**2106-2-13**] 05:35AM BLOOD PT-35.0* INR(PT)-3.6* [**2106-2-18**] 04:25AM BLOOD PT-24.1* PTT-41.7* INR(PT)-2.3* [**2106-1-7**] 08:21PM BLOOD PT-13.1 PTT-28.6 INR(PT)-1.1 [**2106-1-7**] 08:21PM BLOOD Glucose-117* UreaN-46* Creat-1.3* Na-138 K-4.0 Cl-104 HCO3-24 AnGap-14 [**2106-1-21**] 01:06AM BLOOD Glucose-124* UreaN-18 Creat-0.9 Na-139 K-5.0 Cl-113* HCO3-21* AnGap-10 [**2106-2-1**] 01:17AM BLOOD Glucose-169* UreaN-29* Creat-0.8 Na-138 K-3.9 Cl-101 HCO3-29 AnGap-12 [**2106-2-18**] 04:25AM BLOOD Glucose-106* UreaN-23* Creat-0.7 Na-135 K-4.5 Cl-103 HCO3-22 AnGap-15 [**2106-2-18**] 04:25AM BLOOD Calcium-8.5 Phos-3.7 Mg-2.1 [**2106-1-7**] 08:21PM BLOOD Calcium-8.5 Phos-3.9 Mg-2.3  Brief Hospital Course: The patient was cleared by urology for surgery in the setting of recent TURP and hematuria.
TEE on POD 1 revealed EF 20%, inferior and lateral wall hypokinesis as well as anterior wall motion abnormality.
Platelet count would drop to 53,000, HIT screen was sent and patient was started on Angiomax, as suspicion for HITT was high.
The patient did develop acute kidney injury with rise in serum Creatinine to 1.6 (from baseline 0.8) and oliguria.
VRE grew from urine and he was started on a course of linezolid on [**2-6**].
He will continue Coumadin for atrial fibrillation and will need follow-up set-up by rehab upon discharge from there.
11. warfarin 1 mg Tablet Sig: One (1) Tablet PO once a day: please check INR [**2-19**] for further dosing has been receiving 0.5-2 mg daily - 1 mg on [**2-17**] and [**2-18**] goal INR 2.0-2.5.
indication Atrial Fibrillation Goal INR 2-2.5 First draw [**2-19**] Friday Please arrange coumadin/INR f/u prior to discharge from facility initial checks Mon-Wed-Fri for minimum of two weeks; then timing per Dr. [**Last Name (STitle) 29070**] or Dr. [**Last Name (STitle) 88151**] (whomever assumes his coumadin care once discharged from rehabilitation.
Discharge Disposition: Extended Care  Facility: [**Hospital6 2222**] - [**Location (un) 538**]  Discharge Diagnosis: Coronary artery disease s/p Off-pump Coronary artery bypass graft x 3 Respiratory failure s/p tracheostomy Atrial Fibrillation Myocardial infarction acute renal failure Urinary tract infection - VRE Benign prostatic hypertrophy with chronic urinary retention Acute on chronic systolic heart failure CVAx2 (last in [**2100**]) on coumadin Chronic obstructive pulmonary disease Chronic bronchitis Hypercholesterolemia Cardiomegaly  Discharge Condition: Alert and oriented x3 nonfocal - when spoken to in mandarin - understands some english Ambulating short distance with walker and assistance Incisions: Sternal - healing well, no erythema or drainage Leg Right and Left - healing well, no erythema or drainage.
indication Atrial Fibrillation Goal INR 2-2.5 First draw [**2-19**] Friday Please arrange coumadin/INR f/u prior to discharge from facility initial checks Mon-Wed-Fri for minimum of two weeks; then timing per Dr. [**Last Name (STitle) 29070**] or Dr. [**Last Name (STitle) 88151**] (whomever assumes his coumadin care once discharged from rehabilitation.
